{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-135285","form_type":"8-K","ticker":"VCNX","cik":"0001205922","company_name":"VACCINEX, INC.","filed_at":"2024-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.577736+00:00","generated_at":"2026-06-02T04:58:14.990095+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Vaccinex shareholders elect directors, approve say-on-pay and incentive plan amendment","bullets":["Elected Jacob Frieberg, Albert Friedberg, and Maurice Zauderer as directors with >425k votes each.","Advisory say-on-pay passed with 521,607 votes for vs 27,555 against.","Shareholders chose annual frequency for future say-on-pay votes (539,907 for 1 year).","First amendment to 2018 Omnibus Incentive Plan approved 403,835 for, 146,143 against.","Ratified Deloitte & Touche as auditor for FY2024 with 674,404 votes for."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-135285","json":"https://secwatch.observer/filing/0001193125-24-135285.json","markdown":"https://secwatch.observer/filing/0001193125-24-135285.md","text":"https://secwatch.observer/filing/0001193125-24-135285.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1205922/000119312524135285/0001193125-24-135285-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1205922/000119312524135285/d800537d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T04:58:14.990095+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"043a52ece13f328b73fd65e640af2a4fc133e4b1","claim":"VACCINEX, INC. shareholders approved Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2024 at the 2024-05-09 meeting.","evidence_excerpt":"Proposal 5. The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. Votes For Votes Against Votes Abstained 674,404 8,972 417","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1205922/000119312524135285/0001193125-24-135285-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-05-09"}],"fact_type":"shareholder_vote"},{"claim_id":"1d8267215e0d8a094284d19bee532c05c34b233d","claim":"VACCINEX, INC. shareholders approved Approval of First Amendment to the Vaccinex, Inc. 2018 Omnibus Incentive Plan at the 2024-05-09 meeting.","evidence_excerpt":"Proposal 4. The Company’s stockholders approved the First Amendment to the Vaccinex, Inc. 2018 Omnibus Incentive Plan. Votes For Votes Against Votes Abstained Broker Non-Votes 403,835 146,143 308 133,507","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1205922/000119312524135285/0001193125-24-135285-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-05-09"}],"fact_type":"shareholder_vote"},{"claim_id":"419e0003a7c4d96a94b064b0f0e326782985adff","claim":"VACCINEX, INC. shareholders approved Election of three directors for three-year terms expiring in 2027 at the 2024-05-09 meeting.","evidence_excerpt":"Proposal 1. The Company’s stockholders elected the following nominees as directors, each to serve for a three-year term expiring in 2027. Director Nominee Votes For Authority Withheld Broker Non-Votes Jacob Frieberg 425,443 124,843 133,507 Albert Friedberg 425,131 124,155 133,507 Maurice Zauderer 425,477 124,809 133,507","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1205922/000119312524135285/0001193125-24-135285-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-05-09"}],"fact_type":"shareholder_vote"},{"claim_id":"b43c6a0b0904133d1c83beb99243ea998d02fb87","claim":"VACCINEX, INC. shareholders approved Non-binding advisory vote on compensation of named executive officers at the 2024-05-09 meeting.","evidence_excerpt":"Proposal 2. The Company’s stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers. Votes For Votes Against Votes Abstained Broker Non-Votes 521,607 27,555 1,124 133,507","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1205922/000119312524135285/0001193125-24-135285-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-05-09"}],"fact_type":"shareholder_vote"},{"claim_id":"b66265047e8e528862eb91e9a1651e39aa0b4f86","claim":"VACCINEX, INC. shareholders approved Advisory vote on frequency of future say-on-pay votes (every year, 2 years, or 3 years) at the 2024-05-09 meeting.","evidence_excerpt":"Proposal 3. The Company’s stockholders determined, on a non-binding advisory basis, that future advisory votes on the compensation of the Company’s named executive officers shall be held every year. Votes For 1 Year Votes For 2 Years Votes For 3 Years Votes Abstained 539,907 1,950 7,045 1,384","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1205922/000119312524135285/0001193125-24-135285-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay frequency"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-05-09"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}